The Peter Attia Drive

Podbit · The Peter Attia Drive

Building strength and muscle mass: how to optimize training, nutrition, and more for longevity (AMA #71 rebroadcast)

Explore episode Jul 6, 2026
Science
Is Strength Causal or Just a Marker? Mendelian Randomization Answers

Building strength and muscle mass: how to optimize training… · Jul 6, 2026 Science

A Mendelian randomization study of 350,000 Finnish biobank participants used genetic scores as proxies for grip strength and found partial causality — higher genetically-predicted grip strength was tied to lower rates of vascular dementia, obesity, type 2 diabetes, and all-cause mortality. Strength isn't just a health signal; it's a health driver.

Where this was said

Grip strength as a simple yet powerful predictor of all-cause mortality

At 20:15 · chapter starts 17:15

Grip strength earns its own chapter because it sits at a rare intersection: easy to measure, highly reproducible, and powerfully predictive. Peter explains that grip is not merely a curious biomarker — it genuinely reflects whole upper-body strength, since virtually all demanding upper-body tasks require grip. The PURE study, one of the largest of its kind at roughly 140,000 participants across 17 countries, found that each 5kg drop in grip strength corresponds to a 16% increase in all-cause mortality. A separate study following adults aged 70 to 79 for seven years divided participants into quartiles of both muscle mass and strength; those in the strongest, most muscular quartiles consistently showed the best Kaplan-Meier survival curves. Peter uses this data not just to make the case for training but to illustrate why testing grip strength in clinical practice has genuine value as a low-cost, high-signal health screen.

Similar podbits

Science
The Placebo Effect Is Not Fake — It Just Belongs to the Story, Not the Drug

#403 ‒ Peptides: separating scientific promise from marketi… · Aug 10, 2026 Science

Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.